DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Autolus Therapeutics Q4 EPS $(0.93) Misses $(0.74) Estimate, Sales $309K Miss $520K Estimate

Autolus Therapeutics (NASDAQ:AUTL) reported quarterly losses of $(0.93) per share which missed the analyst consensus estimate of $(0.74) by 25.68 percent. This is a 78.85 percent decrease over losses of $(0.52) per share

Benzinga · 03/03/2020 12:20

Autolus Therapeutics (NASDAQ:AUTL) reported quarterly losses of $(0.93) per share which missed the analyst consensus estimate of $(0.74) by 25.68 percent. This is a 78.85 percent decrease over losses of $(0.52) per share from the same period last year. The company reported quarterly sales of $309 thousand which missed the analyst consensus estimate of $520 thousand by 40.58 percent. This is a 4.39 percent increase over sales of $296 thousand the same period last year.